PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574975
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574975
Artificial Intelligence (AI) and Analytics in Surgery Market size was valued at USD 187.90 Million in 2023, expanding at a CAGR of 26.90% from 2024 to 2032.
The Artificial Intelligence (AI) and Analytics in Surgery Market involves the integration of advanced AI technologies and data analytics into surgical practices to enhance precision, efficiency, and patient outcomes. AI-powered systems assist in pre-operative planning, real-time decision-making during surgery, and post-operative care through data-driven insights and predictive analytics. Increasing adoption of AI-driven surgical robots, like the da Vinci Surgical System, and analytics platforms are transforming traditional surgery by improving accuracy and reducing human error. However, challenges such as high costs, data privacy concerns, and the need for extensive clinical validation could hinder widespread adoption. Opportunities lie in expanding AI applications in minimally invasive and robotic surgeries, supported by favorable regulatory approvals. For instance, the U.S. FDA has approved several AI-based surgical tools, indicating growing acceptance and market potential.
Artificial Intelligence (AI) and Analytics in Surgery Market- Market Dynamics
Increasing Adoption of AI-Driven Surgical Robots Revolutionizes the Surgery Market
The increasing adoption of AI-driven surgical robots is transforming the surgery market by enhancing precision, reducing complications, and improving patient outcomes. Leading healthcare institutions like the Mayo Clinic and Cleveland Clinic have integrated AI-enabled robotic systems into their surgical suites, allowing for more precise procedures in complex surgeries such as neurosurgery and oncology. For instance, the da Vinci Surgical System, developed by Intuitive Surgical, is widely used across hospitals worldwide, providing surgeons with enhanced visualization and dexterity. The U.S. FDA has also approved AI-based platforms like the Mazor X robotic guidance system for spine surgery, indicating a growing regulatory acceptance. Additionally, initiatives such as the UK's National Health Service (NHS) exploring AI-driven tools for surgery highlight global interest in leveraging AI to advance surgical practices, reduce hospital stays, and lower overall healthcare costs.
Artificial Intelligence (AI) and Analytics in Surgery Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 26.90% over the forecast period (2024-2032)
Based on Solution Type segmentation, AI-Assisted Surgical Robots were predicted to show maximum market share in the year 2023
Based on Surgical Specialty segmentation, General Surgery was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Artificial Intelligence (AI) and Analytics in Surgery Market is segmented on the basis of Solution Type, Surgical Specialty, Application, and Region.
The market is divided into three categories based on Solution Type: AI-Based Software Solutions, Analytics Platforms, and AI-Assisted Surgical Robots. AI-Assisted Surgical Robots hold the highest priority due to their transformative impact on precision and outcomes in surgeries. AI-Based Software Solutions follow, enhancing decision support and workflow efficiency, while Analytics Platforms rank third, providing data-driven insights for surgical improvements.
The market is divided into four categories based on Surgical Specialty: General Surgery, Orthopedic Surgery, Neurosurgery, and Cardiac Surgery. General Surgery holds the highest priority due to its broad application across various procedures. Orthopedic Surgery follows with significant adoption of AI tools for precision. Neurosurgery and Cardiac Surgery rank third and fourth, respectively, focusing on high-complexity interventions.
Artificial Intelligence (AI) and Analytics in Surgery Market- Geographical Insights
North America is the leading region in the Artificial Intelligence (AI) and Analytics in Surgery Market, primarily driven by the robust healthcare infrastructure and early adoption of advanced surgical technologies. The U.S. is at the forefront, with institutions like Johns Hopkins and the Mayo Clinic utilizing AI-driven platforms for surgical planning and intraoperative guidance. The FDA's approval of several AI-based surgical systems has also facilitated rapid market growth in the region. In Europe, countries like Germany and the UK are investing heavily in AI research and development for surgical applications, supported by government initiatives such as the UK's £250 million investment in AI labs under the NHS AI Lab initiative. Meanwhile, the Asia-Pacific region, particularly China and Japan, is witnessing significant growth due to the increasing focus on healthcare modernization and the incorporation of AI in medical procedures. China's government-backed "Health China 2030" plan encourages the integration of AI in healthcare, aiming to establish a more efficient and precise surgical ecosystem.
North America dominates the competitive landscape of the Artificial Intelligence (AI) and Analytics in Surgery Market, with key players like Intuitive Surgical and Medtronic pioneering AI-driven surgical solutions. The U.S. market is bolstered by extensive R&D investments and strategic collaborations, such as the partnership between Johnson & Johnson and Google's Verily to develop advanced surgical robots. In Europe, companies like Siemens Healthineers and Philips are leading the AI surgery segment, leveraging initiatives like the European Union's "AI4EU" project, which supports AI innovation in healthcare. The Asia-Pacific region is emerging as a formidable competitor, driven by significant investments in healthcare AI by Chinese tech giants such as Tencent and Alibaba. The Chinese government's support through its "Next Generation AI Development Plan" further accelerates advancements in surgical AI. Japan also contributes to regional competitiveness, with companies like Sony and Olympus investing in AI-enhanced surgical imaging systems. These developments underscore the dynamic and evolving nature of the market across key regions.
In July 2024, Medtronic launched its Touch Surgery Live Stream platform, featuring 14 AI algorithms that enhance surgical insights for laparoscopic and robotic-assisted procedures. This technology aims to improve post-operative analysis and create immersive virtual learning environments for surgeons and trainees.
In March 2024, Johnson & Johnson MedTech is collaborating with NVIDIA to enhance AI in surgery, enabling real-time data analysis and deployment of AI algorithms within its surgical ecosystem. This partnership aims to improve surgical decision-making, education, and collaboration globally.